A Route to Potent, Selective, and Biased Salvinorin Chemical Space.
Sarah J Hill, Nathan Dao, Vuong Q. Dang, Edward L Stahl, Laura M Bohn, Ryan A Shenvi
ACS Central Science August 23, 2023 DOI: 10.1021/acscentsci.3c00616 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Salvia divinorum |
| Key points | A short asymmetric synthesis using a sterically confined organocatalyst and cobalt-catalyzed cycloaddition enables divergent access to salvinorin analogs that exceed the potency, selectivity, stability, and functional bias of salvinorin A. |
Abstract
The salvinorins serve as templates for next generation analgesics, antipruritics, and dissociative hallucinogens via selective and potent agonism of the kappa-opioid receptor (KOR). In contrast to most opioids, the salvinorins lack basic amines and bind with high affinity and selectivity via complex polyoxygenated scaffolds that have frustrated deep-seated modification by synthesis. Here we describe a short asymmetric synthesis that relies on a sterically confined organocatalyst to dissociate acidity from reactivity and effect Robinson annulation of an unactivated nucleophile/unstable electrophile pair. Combined with a cobalt-catalyzed polarized diene-alkyne cycloaddition, the route allows divergent access to a focused library of salvinorins. We appraise the synthesis by its generation of multiple analogs that exceed the potency, selectivity, stability, and functional bias of salvinorin A itself.
Citations in the library
Cited by 5
- Natural Product Synthesis in the 21st Century: Beyond the Mountain Top ACS Central Science February 14, 2024
- A chromosome level reference genome of Diviner's sage (Salvia divinorum) provides insight into salvinorin A biosynthesis. BMC plant biology October 1, 2024
- Stereoselective Robinson Annulation Enables Access to Potent and Selective Salvinorin Analogs Synfacts September 14, 2023
- Salvaging Salvinorin: From Hallucinogen to Potential Therapeutic through Chemical Synthesis ACS Central Science August 10, 2023
- Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening. Journal of Medicinal Chemistry August 22, 2024
Cites 19
- Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences September 3, 2002
- Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans. Neuroimage July 1, 2008
- Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors. Biochemistry June 21, 2005
- Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V June 1, 2009
- Total synthesis of the hallucinogenic neoclerodane diterpenoid salvinorin A. Organic Letters April 3, 2008
and 14 more in the library